226 related articles for article (PubMed ID: 21134296)
1. Is there a linear relationship between the Brief Psychiatric Rating Scale and the Clinical Global Impression-Schizophrenia scale? A retrospective analysis.
Sawamura J; Morishita S; Ishigooka J
BMC Psychiatry; 2010 Dec; 10():105. PubMed ID: 21134296
[TBL] [Abstract][Full Text] [Related]
2. Associations between symptom severity and well-being among Thai patients with schizophrenia: a cross-sectional analytical study.
Teetharatkul T; Vitayanont A; Liabsuetrakul T; Aunjitsakul W
BMC Psychiatry; 2021 Jul; 21(1):348. PubMed ID: 34253169
[TBL] [Abstract][Full Text] [Related]
3. Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia.
Lee J; Fervaha G; Takeuchi H; Powell V; Remington G
J Clin Psychopharmacol; 2015 Jun; 35(3):237-41. PubMed ID: 25839337
[TBL] [Abstract][Full Text] [Related]
4. Linking the PANSS, BPRS, and CGI: clinical implications.
Leucht S; Kane JM; Etschel E; Kissling W; Hamann J; Engel RR
Neuropsychopharmacology; 2006 Oct; 31(10):2318-25. PubMed ID: 16823384
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the Brief Psychiatric Rating Scale and the Scale for the Assessment of Negative Symptoms: a study of their correlation and redundancy.
Czobor P; Bitter I; Volavka J
Psychiatry Res; 1991 Feb; 36(2):129-39. PubMed ID: 2017528
[TBL] [Abstract][Full Text] [Related]
6. The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity.
Bell M; Milstein R; Beam-Goulet J; Lysaker P; Cicchetti D
J Nerv Ment Dis; 1992 Nov; 180(11):723-8. PubMed ID: 1431824
[TBL] [Abstract][Full Text] [Related]
7. Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.
Takahashi H; Kamata M; Yoshida K; Ishigooka J; Higuchi H
J Clin Psychiatry; 2006 Oct; 67(10):1577-82. PubMed ID: 17107250
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of Brief Psychiatric Rating Scale scores.
Leucht S; Kane JM; Kissling W; Hamann J; Etschel E; Engel R
Br J Psychiatry; 2005 Oct; 187():366-71. PubMed ID: 16199797
[TBL] [Abstract][Full Text] [Related]
9. Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia.
Suzuki T; Uchida H; Sakurai H; Ishizuki T; Tsunoda K; Takeuchi H; Mimura M
Psychiatry Res; 2015 Jun; 227(2-3):265-9. PubMed ID: 25882098
[TBL] [Abstract][Full Text] [Related]
10. [Dimensional structure of the German version of the Brief Psychiatric Rating Scale (BPRS)].
Mass R; Burmeister J; Krausz M
Nervenarzt; 1997 Mar; 68(3):239-44. PubMed ID: 9198784
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
[TBL] [Abstract][Full Text] [Related]
12. The Brief Psychiatric Rating Scale. Dimension of schizophrenia--reliability and construct validity.
Andersen J; Larsen JK; Schultz V; Nielsen BM; Kørner A; Behnke K; Munk-Andersen E; Butler B; Allerup P; Bech P
Psychopathology; 1989; 22(2-3):168-76. PubMed ID: 2762476
[TBL] [Abstract][Full Text] [Related]
13. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
[TBL] [Abstract][Full Text] [Related]
14. Equipercentile linking of the BPRS and the PANSS.
Leucht S; Rothe P; Davis JM; Engel RR
Eur Neuropsychopharmacol; 2013 Aug; 23(8):956-9. PubMed ID: 23433639
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia.
Newcomer JW; Faustman WO; Yeh W; Csernansky JG
Psychiatry Res; 1990 Mar; 31(3):243-50. PubMed ID: 2333356
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of standardized psychometric scales (BPRS, HDS)in the evaluation of schizophrenic symptoms (preliminary report)].
Linka M; Rybakowski J
Psychiatr Pol; 1990; 24(1):15-22. PubMed ID: 2284354
[TBL] [Abstract][Full Text] [Related]
17. Symptom rating scales and outcome in schizophrenia.
Mortimer AM
Br J Psychiatry Suppl; 2007 Aug; 50():s7-14. PubMed ID: 18019038
[TBL] [Abstract][Full Text] [Related]
18. Does catatonia influence the phenomenology of childhood onset schizophrenia beyond motor symptoms?
Bonnot O; Tanguy ML; Consoli A; Cornic F; Graindorge C; Laurent C; Tordjman S; Cohen D
Psychiatry Res; 2008 Apr; 158(3):356-62. PubMed ID: 18272234
[TBL] [Abstract][Full Text] [Related]
19. The effects of clozapine on symptom clusters in treatment-refractory patients.
Abraham G; Nair C; Tracy JI; Simpson GM; Josiassen RC
J Clin Psychopharmacol; 1997 Feb; 17(1):49-53. PubMed ID: 9004057
[TBL] [Abstract][Full Text] [Related]
20. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
